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Onchocerciasis is a severe parasitic infection which causes disabling skin and subcutaneous 
tissue changes. The disease is endemic in many African countries including Ethiopia. In 2013, 
Ethiopia launched Onchocerciasis elimination program with the goal of attaining interruption of 
onchocerciasis transmission nationwide by 2020. The country has successfully scaled up 
interventions and achieved 100% geographic coverage in all known endemic districts. The main 
strategy for interrupting the disease is mass drug administration (MDA) delivered two times per 
year. The treatment coverage for the last five years has been maintained at more than 80%. 
Despite many years of ivermectin MDA the transmission of onchocerciasis in many districts 
remained unabated. To achieve the 2020 goal, sustained high geographic and therapeutic 
coverage is required which is validated by coverage surveys. The programme should aim to 
improve the knowledge and attitude of the community towards the programme in order to 
improve drug compliance. The partnership between the relevant stakeholders should be 
strengthened to facilitate open discussions regarding the programme implementation and any 
challenges that may arise in the control and elimination of the disease.  It is also important to 






Onchocerciasis (river blindness) is one of the debilitating neglected tropical diseases (NTDs)[1] 
that have drawn the attention of national governments, non-governmental organizations, 
pharmaceutical companies, philanthropists and health development practitioners worldwide. 
Onchocerciasis is an eye and skin disease caused by filarial worm called Onchocerca volvulus, 
which is transmitted by the bite of an infected black fly, of the genus Simulium[1]. These flies 
breed in fast-flowing streams and rivers, hence the name “river blindness.” People with 
infections can experience severe itching, dermatitis, eye lesions, and/or subcutaneous 
nodules[1]. In most of the endemic countries, blindness is inevitable for those with severe and 
chronic infections, though this is not the case in Ethiopia[1,2]. The disease is one of the 
underlying causes of poverty amongst the communities where it is prevalent. The socio-
economic implications of onchocerciasis are significant as the disease impacts on the lives of  
individuals and communities in endemic countries[1].  
Worldwide there are 120 million people at risk of onchocerciasis, of which 96% are in Africa[3]. . 
In parts of Africa, the disabling consequences of onchocerciasis led to migration of people away 
from fertile riverine land, and the disease still constitutes an obstacle to development in certain 
areas where disease control measures have not yet been fully implemented[4,5]. According to 
the World Health Organization (WHO), 6.5 million people who have the disease suffer from 
dermatologic manifestations and 270,000 are blind[3].  
In Ethiopia more than 17 million people live in the surveyed endemic areas of Ethiopia and are 
affected by the disease, or are at risk of infection. Studies conducted so far in Ethiopia indicated 
that the disease is mostly found in South-Western, Western and North-Western parts of the 
country[6].  
Ethiopia launched onchocerciasis elimination programme with the goal of attaining the 
interruption of onchocerciasis transmission nationwide by 2020[6]. This manuscript describes 
the onchocerciasis elimination programme in Ethiopia with emphasis on the milestones, and 
lessons learnt through the implementation of the programme. 
Burden, epidemiology and geographical distribution of onchocerciasis in Ethiopia 
In Ethiopia, the disease has been known since 1939 following investigations by Italian 
researchers in South-Western Ethiopia[7].  It is a disease of public health and socio-economic 
importance in the country and is endemic in 188 districts with an estimated 17 million people at 
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risk of the disease(Table 1) [6]. In 2013, onchocerciasis was responsible for 34,600 disability-
adjusted life-years (DALYs) lost [8].  The main symptom of the disease is dermal manifestations 
that are characterized by intense itching and thickening of the skin, hanging groin and 
depigmentation of the skin[9]. In a study conducted on Ethiopian immigrants living in Israel, the 
most common clinical manifestation found was chronic popular onchodermatitis, found in more 
than 46 patients (55%); with depigmentation and atrophy found in 13 (15%) and 12 (14%) of the 
study participants; respectively[10]. 
 
The western part of Ethiopia, where many rivers with vegetation provide a suitable habitat for 
the vector, was found to be endemic for onchocerciasis following rapid epidemiological mapping 
of onchocerciasis (REMO) (Figure 1)[6]. In these mapped areas, the prevalence of 
onchocerciasis is highest in places that are close to rivers, with the prevalence dropping 
gradually as one moves further away from the rivers[6]. The central highlands and arid lowlands 
of Ethiopia are generally thought to be free of onchocerciasis, most likely due to the highlands 
low temperature and the lowlands absence of fast flowing rivers, dry weather and lack of 
suitable vegetation, which are unsuitable environments for both the vector and the parasite[6]. 
However, mapping of onchocerciasis in the eastern part of the country was not done due to lack 
of historical evidence and presumed ecological unsuitability for transmission. Parts of regional 
states of Amhara, Oromia, Southern Nations, Nationalities and Peoples, and Gambella and all 











Lymphatic filariasis (LF) is a parasitic disease that is transmitted by mosquitoes, clulex and 
ades. It causes   elephantiasis. Onchocerciasis and LF have overlapping endemicity in many 
parts of Africa and Ethiopia is no exception. There is also an LF elimination effort in Ethiopia 
(with a similar national goal of transmission interruption by 2020) and both elimination 
programmes use ivermectin MDA (in LF MDA, ivermectin is combined with albendazole, 
donated by GSK). Coordination of onchocerciasis and LF elimination efforts is essential in foci 
where co-endemicity exists so that elimination of both diseases can be achieved in an 
integrated fashion, especially regarding transmission assessments. In Ethiopia, there are 45 co-
endemic districts (Table 2). 
Table 2: Distribution of onchocerciasis and LF co-endemic districts in Ethiopia 
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Socio-economic impact  
Beyond the debilitating health burden, onchocerciasis also inflicts tremendous social and 
economic damage on individuals and entire communities. In a case-control study conducted to 
determine the effect of non-blinding onchocerciasis on work productivity at Baya farm in Teppi 
coffee plantation project; cases had a significantly lower total household income and lower 
average per capita income. Cases were significantly more likely to be absent from their work 
due to illness and unauthorized leave than controls and, furthermore, controls earned a 25.2% 
Table 1 Distribution of onchocerciasis by region 









increase over the salary earned than cases and spent a larger proportion of their income on 
health costs[11].  
Evolution of NTDs program  
Few years ago NTDs were not given the required attention at various levels. Although disease 
specific interventions exist, there were no coordinated NTD interventions in Ethiopia. Data on 
the burden and distribution of NTDs were incomplete; access to preventive and curative 
services were inadequate and not well integrated. Thus, NTDs continued to debilitate, deform, 
blind and kill sizeable proportions of the population either as mono-infections or as co-infections 
with major killers such as HIV/AIDS. Cognizant of this, Ethiopia lunched the first NTD 
masterplan in May 2013 and the second version in 2016[6,12]. NTDs were also included in the 
country’s 5-year Health Sector Transformation Plan (HSTP)[13]. 
Programme Implementation  
 
The first REMO was conducted in 2000-2001 and MDA was launched in 2001 in the then Kafa-
Sheka Zone. Since 2012, the country has been implementing onchocerciasis elimination 
strategies in all endemic districts. Preventive chemotherapy using MDA is the main intervention 
strategy. MDA is conducted by community drug distributors through the health development 
army. Health education is one of the strategies to raise the awareness of the communities and 
mobilize them before and during MDA (Figure 9). Out of 188 endemic districts, 184 are eligible 
for bi-annual treatment based on the criteria set by the Ethiopian Onchocerciasis Elimination 
Expert Advisory Committee (EOEEAC) in 2014 to ensure interruption of onchocerciasis 
transmission by 2020. Enlisted below is summary timeline of historical data: 
• First REMO conducted in 2000 - 2001  
• Onchocerciasis MDA was launched in 2001 in the then Kafa-Sheka Zone 
• The first skin snip survey was conducted in Kafa-Sheka and Bench Maji Zones and 
treatment with Ivermectin was started in 2001 
• TDs Masterplan launched in 2013 
• Entomological survey commenced in 2013 and expanded to all endemic and suspected 
areas /zones. 
• The first three black fly collection sites were selected and established in 2013, in Jimma, 
Shaka and Bench Maji zones. 
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• EOEEAC was established in October 2014. 
• Onchocerciasis elimination guideline was launched in October 2015. 
• Onchocerciasis molecular laboratory established at Ethiopian Public Health Institute in 
October 2015 
Mass drug administration (MDA) process 
The health development army are responsible for distributing the medication to eligible 
individuals.  The approach used in most of the communities includes training sessions prior to 
each activity. It all starts with zonal-level ‘training of trainers’ which is then followed by district-
level training of HEWs before the first semiannual MDA for each year. This training is then 
shortly cascaded to health development army. This high level of community ownership has 
helped to create required level of community awareness and overcome the challenges imposed 
due to inadequate MDA coverage. Training for community leaders is conducted to sensitize and 
educate them about onchocerciasis, including how to organize the MDA. Training sessions on 
health communication are also organized in each community and focus on a number of key 
messages related to onchocerciasis treatment, transmission, and prevention, as well as the 
clinical manifestations of onchocerciasis. Training is followed by an intense community 
mobilization campaign using available media including banners, posters, audio spots on local 
radio stations, and messages delivered by megaphones to inform and encourage the population 
to participate in the MDA. Different types of posters have been distributed to each village and 
posted in a range of places to increase visibility. Community mobilization and sensitization is 
also conducted by health extension workers and the health development army at each village 
using existing opportunities such as social and religious gatherings and local market places 
where people are gathered. The community elders and the community administration, as well as 
the community at large are key players in facilitating the MDA activities. Finally, following the 
distribution, reported coverage data aggregated by age and gender is collected from each 
distribution post to the respective districts then rolls up to zonal health departments, regional 
health bureaus and finally submitted to the Federal Ministry of Health (FMOH).  
Mass Drug Administration (MDA) Progress 
Onchocerciasis MDA in Ethiopia was started in 2001 in the then Kefa-Sheka Zone with the 
support of APOC (African Programme for Onchocerciasis Control). The prevalence of skin 
nodules was used to initiate MDA. Since then, the treatment has expanded and scaled up to all 
known endemic districts and now there are about 14 million people in 188 districts under 
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ivermectin treatment each year. The reported MDA coverage has gradually increased since 
then and the latest for 2015/6 was 81% (Figure 2). The mass drug administration has been 
extended to work force in development scheme with regular support through supervision and 
review meeting.  
 
Figure 2: Trends in onchocerciasis treatment since 2001 
Four times a year treatment  
Four times a year MDA for onchocerciasis has shown great impact to interrupt transmission in 
Latin America[14]. In line with WHO’s recommendation Ethiopia has set an ambitious goal to 
interrupt onchocerciasis transmission by 2020. However, with mapping not completed in some 
areas and treatment over ten years having not interrupted transmission in many districts of the 
country, the need to shift gear it is essential to change gears from twice a year treatment to four 
times a year treatment. This is particularly important in areas where the health system is 
performing very well, where transmission is still ongoing following impact assessments, and in 
newly identified endemic districts to speed-up the elimination. 
Integrated NTD program  
Five preventive chemotherapy (PC)-NTDs (trachoma, onchocerciasis, lymphatic filariasis, 
schistosomiasis and STH) are common in Ethiopia, majority of them are co-endemic in the 
same districts.  PC is being used as one of the main strategy to eliminate and control majority of 
10 
 
NTDs in Ethiopia. There is insufficient funding and technical assistance that can aid the MOH to 
carry out these programs throughout the country. The scale up of intervention is being 
compromised by inappropriate utilization of resources. This has enforced the implementation of 
cost-efficient NTD control programs where disease-specific programs are integrated and 
coordinated by the trainings, logistic distribution, social mobilization and monitoring activities. 
This is believed to link the programs effectively with other elements of the health system. 
Onchocerciasis is not an exception from these integrations. The onchocerciasis elimination 
strategies have been included in the integrated refresher training manual for HEWs. Indicator for 
onchocerciasis mass drug administration has been included in the health management 
information system. 
Monitoring and Evaluation 
The monitoring and evaluation of the onchocerciasis programme involves coverage surveys, 
epidemiological, parasitological and entomological assessments. The coverage surveys are 
conducted in selected districts to validate programme coverage. The epidemiological and 
parasitological assessments are usually conducted after 10 rounds of treatment and they are 
supplemented with entomological surveys. In Ethiopia so far, we report complete geographic 
coverage in all known endemic districts and therapeutic coverage has reached 81 percent of the 
total population. Impact assessment conducted using epidemiologic, parasitological and 
entomologic assessments showed that there are districts with ongoing transmission that can 
maintain endemicity in the absence of MDA. The onchocerciasis flag prepared at the end of 
2016 to monitor the progress of the programme, indicated that there were no districts in Ethiopia 
that have declared interruption of transmission. However, there are two districts in North Gondar 
that have been found to be negative for all impact assessments but their closeness to endemic 
districts with ongoing transmission makes it difficult to declare them as having interrupted 
transmission of onchocerciasis (Table 3).  
 Table 3: Impact assessment results from North Gondar 
District Year MDA started No of treatment 
rounds 
No of positive pool/total 
pool 
Metema 2003 15 2/68 
Quara 2003 15 2/145 
Tach Armacho 2004 14 0/2 




In Teppi, South-Western Ethiopia, a study was conducted to assess the status of 
onchocerciasis after four years of annual community directed treatment with ivermectin (CDTI) 
and the result indicated that 69 (25.5%) individuals age >10 years  were found to be positive for 
microfilaremia and the microfilarial load of the positive individuals ranged from 0.08 – 8mf (mean 
1.3) per gm of skin snip which was significantly  lower  than  prevalence  (81%)  and  intensity  
of  infection  (0- 855, mean 33 ± 5.6)  reported  before the initiation of the CDTI programme in 
the study  area[15].In another study conducted in Anfilo district, Kelem Wollega Zone, Western 
Ethiopia, after six successive years of annual ivermectin mass treatment the prevalence of 
microfilaria reduced from the pre-intervention value of 74.8% to 40.7%, indicating a 45.6% 
reduction, mean intensity from 32.1(SD=61.5) mf/mg skin snip to 18.7(SD=28.7) indicating a 
41.75% reduction, CMFL from 19.6 mf/mg skin snip to 4.7 indicating a 76% reduction. There 
was a statistically significant difference this reduction (P<0.05)[16].These results also showed 
that the prevalence of microfilaria and mean intensity decreased as the number of treatment 
taken increased (Figure 3&4).  
 
 
Figure1.  Prevalence of infection versus frequency of treatment, in Anfilo district, Kelem Wollega      

























Figure 2. Number of MDA given versus mean intensity of infection, Anfilo District, Kelem 
Wollega Zone, February – April, 2012 
Entomological assessment 
Fly collection site has been established in different part of the country with the objective to 
confirm transmission interruption and monitor intra and inter border transmission. The 
entomological assessment is also important to decide cessation of MDA in transmission zones 
and it is directly supervised by Ethiopian Public Health Institute (EPHI).  
Cross-border collaboration 
Onchocerciasis transmission zones appear to cross the border between the Sudan, the 
Republic of South Sudan (RSS), and Ethiopia. In addition, there is continuous movement of 
people who are possibly infected among these countries. The programme has initiated cross 
border activity with Sudan and started collaborative work to determine the existence of cross 
border transmission and to improve surveillance of cross border transmission.  
Partnership  
The FMOH provides overall policy direction, coordinates and creates an enabling environment 
so that stakeholders and partners can contribute to the country’s efforts towards achieving the 
envisaged elimination goal by 2020. The FMOH has used the increasing interest from donors 
























and pharmaceutical companies to manage the agenda of onchocerciasis elimination and 
through fruitful discussions with developmental partners, has laid out the way for technical and 
financial support. Over the past many years, Ethiopian Onchocerciasis Elimination Programme 
enjoyed the generous support from WHO/APOC (World Health Organization/African 
Programme for Onchocerciasis Control), MDP (Mectizan Donation Program) and NGDOs (Non-
Governmental Development Organizations. The partnership has helped the effort to scale-up 
onchocerciasis elimination interventions in all known endemic districts of the country. 
The FMOH also established the EOEEAC with the objective of soliciting technical advice from 
high-level experts on onchocerciasis elimination. This advisory committee is composed of 
national and international experts, as well as FMOH staff from all endemic regions of Ethiopia. 
The committee reviews annual progress made by the onchocerciasis elimination programme 
and provides recommendation to update the Ethiopian ‘onchocerciasis flag’, which will be a 
visual table, color-coded by focus according to the four stages of elimination depicted in the 
WHO guidelines. Furthermore, the committee recommends altering or halting interventions.  In 
addition, a national onchocerciasis Technical Working Group (TWG) has been established 
which is composed of stakeholders, implementing partners, research and teaching institutes. 
The TWG, under the auspices of the National NTD Taskforce (NNTF) advises the FMOH on 
strategic issues.  
 
The main partners that support the onchocerciasis elimination programme in Ethiopia are The 
Carter Center (TCC), Research Triangle Institute (RTI) and Light for the World (LTW). TCC 
support 112 districts in Oromia, Amhara, SNNPR, Gambella and Benishangul. RTI supports 14 
districts in Benishangul-gumuz and LTW supports 64 districts in Oromia (Figure 5). Moreover, 
WHO provided technical and financial support for the national delineation survey for 
onchocerciasis transmission and entomological surveys for programme evaluation. The 
Ethiopian Public Health Institute (EPHI) with support of WHO/APOC has played a prominent 
role in the onchocerciasis mapping in most parts of the country. Other universities and research 
institutions help to fill gaps on the transmission dynamics of the disease, not only by gathering 
and disseminating new knowledge from elsewhere, but also by undertaking small and large-




Figure 5. Partners map of onchocerciasis 
Major programme implementation challenges towards onchocerciasis elimination 
Mapping has been completed for most of the country but there are still some areas in the 
eastern part which require mapping and there are also a few areas in the western part which 
require additional information to enable evidence based decisions making on the need for 
intervention. Although experts have differing perspectives on the need for mapping in the 
eastern part of the country due to ecologic factors that do not favor the disease transmission, it 
is considered important to assess the whole country to be successfully verified for 
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onchocerciasis elimination. The absence of regular coverage surveys to validate programme 
reports and failure to reduce the disease prevalence below the minimum threshold level after 
many years of MDA might pose potential challenges including refusal by the communities to 
take ivermectin during MDA, staff demotivation, drug resistance, donor fatigue and resultant 
uncertainty of drug donations. Lack of well documented activities, reports and data at all level 
could also affect the verification process once onchocerciasis is eliminated. 
Conclusion 
Ethiopia envisaged to interrupt onchocerciasis transmission by 2020 and to be certified free 
from onchocerciasis by 2025. This goal requires strong programme implementation and 
monitoring in collaboration with developmental partners. There should be full geographic 
coverage and above the minimum recommended therapeutic coverage. In order to ensure that 
high MDA coverage is maintained MDA coverage surveys have to be carried out on regular 
basis. The programme should aim to improve communities’ active involvement in the selection 
of community drug distributors, determination of sites for MDA and provide locally appropriate 
incentives (monetary and non-monetary) to the CDDs. Health workers and CDDs should put 
concerted effort to enhance knowledge of the communities on the disease, adherence to MDA 
and attitude towards the programme in endemic districts so as to increase MDA coverage and 
expedite interruption of onchocerciasis transmission. Furthermore, it is essential to improve 
capacity at all levels to ensure proper programme management. The partnership between all 
relevant stakeholders should be strengthened to facilitate open discussions around the 
programme and allow knowledge transfer to accelerate control and elimination of the disease. 
The country should consider other feasible interventions, such as vector control/elimination 
when and where applicable. 
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